Aditxt Inc. Insider Trading

ADTX

Last 12 months

Insiders sold $5 and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Chief M&A Officer Corinne Pankovcin sold $3 on Nov 25, 2025, 100% of their stake, outside a plan. The last open-market buy by an executive or director was in Jul 2022.

Net open-market

−$5

0 buys · 2 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

Jul 2022

Jul 19, 2022

Get an email when ADTX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 23	Takeover Time 2026 LLC Large holder	SoldNo plan	3,420,439	$0.02	68K	100%	Form 4
Jun 22	HRT Financial LP Large holder	SoldNo plan	5,120,480	$0.02	102K	100%	Form 4
Jun 18	HRT Financial LP Large holder	Bought	7,340,178	$0.01	73K	New	Form 4
Jun 17	DRW Securities, LLC Large holder	SoldNo plan	126,772	$0.01	1K	100%	Form 4
Jun 16	HRT Financial LP Large holder	SoldNo plan	3,132,480	$0.01	31K	100%	Form 4
Jun 15	HRT Financial LP Large holder	Bought	2,114,344	$0.01	21K	86%	Form 4
Jun 12	HRT Financial LP Large holder	Bought	4,252,767	$0.02	85K	New	Form 4
Jun 11	Bofa Securities, Inc. Large holder	SoldNo plan	15	$0.01	$0	23%	Form 4
Jun 11	Bofa Securities, Inc. Large holder	Bought 5 parts	7	$0.01 average	$0	17%	Form 4
Jun 11	HRT Financial LP Large holder	SoldNo plan	2,833,463	$0.01	28K	100%	Form 4
Jun 8 – 10	HRT Financial LP Large holder	Bought 2 parts	2,148,823	$0.04 average	86K	New	Form 4
Jun 9	HRT Financial LP Large holder	SoldNo plan	878,659	$0.03	26K	46%	Form 4
Jun 9	Sandie Gong Large holder	SoldNo plan	100,000	$0.07	7K	100%	Form 4
Jun 5	HRT Financial LP Large holder	SoldNo plan	735,462	$0.06	44K	100%	Form 4
Jun 4	HRT Financial LP Large holder	Bought	843,622	$0.08	67K	New	Form 4
Apr 23 – 24	HRT Financial LP Large holder	SoldNo plan 2 parts	33,215	$0.28 average	9K	27%	Form 4
Apr 22	HRT Financial LP Large holder	SoldNo plan	11,982	$0.30	4K	9.0%	Form 4
Apr 21	HRT Financial LP Large holder	Bought	72,912	$0.33	24K	150%	Form 4
Dec 17, 2025	Brian Michael Brady Director	SoldNo plan	1	$1.75	$2	25%	Form 4
Nov 25, 2025	Corinne Pankovcin Chief M&A Officer	SoldNo plan	1	$3.20	$3	100%	Form 4

Jun 23No plan
Takeover Time 2026 LLC
Large holder · sold 3,420,439 at $0.02
68K
100% of stake
Jun 22No plan
HRT Financial LP
Large holder · sold 5,120,480 at $0.02
102K
100% of stake
Jun 18
HRT Financial LP
Large holder · bought 7,340,178 at $0.01
73K
New position
Jun 17No plan
DRW Securities, LLC
Large holder · sold 126,772 at $0.01
1K
100% of stake
Jun 16No plan
HRT Financial LP
Large holder · sold 3,132,480 at $0.01
31K
100% of stake
Jun 15
HRT Financial LP
Large holder · bought 2,114,344 at $0.01
21K
86% of stake
Jun 12
HRT Financial LP
Large holder · bought 4,252,767 at $0.02
85K
New position
Jun 11No plan
Bofa Securities, Inc.
Large holder · sold 15 at $0.01
$0
23% of stake
Jun 11
Bofa Securities, Inc.
Large holder · bought 7 at avg $0.01
$0
17% of stake
Jun 11No plan
HRT Financial LP
Large holder · sold 2,833,463 at $0.01
28K
100% of stake
Jun 8 – 10
HRT Financial LP
Large holder · bought 2,148,823 at avg $0.04
86K
New position
Jun 9No plan
HRT Financial LP
Large holder · sold 878,659 at $0.03
26K
46% of stake
Jun 9No plan
Sandie Gong
Large holder · sold 100,000 at $0.07
7K
100% of stake
Jun 5No plan
HRT Financial LP
Large holder · sold 735,462 at $0.06
44K
100% of stake
Jun 4
HRT Financial LP
Large holder · bought 843,622 at $0.08
67K
New position
Apr 23 – 24No plan
HRT Financial LP
Large holder · sold 33,215 at avg $0.28
9K
27% of stake
Apr 22No plan
HRT Financial LP
Large holder · sold 11,982 at $0.30
4K
9.0% of stake
Apr 21
HRT Financial LP
Large holder · bought 72,912 at $0.33
24K
150% of stake
Dec 17, 2025No plan
Brian Michael Brady
Director · sold 1 at $1.75
$2
25% of stake
Nov 25, 2025No plan
Corinne Pankovcin
Chief M&A Officer · sold 1 at $3.20
$3
100% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ADTX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ADTX

CompareIntrinsic value

GCANThe Greater Cannabis Company, Inc.

$0.75+0.00%20

SKVISkinvisible Inc.

$0.16+0.00%0

GNLXGenelux Corp.

$1.96+2.08%10

PHIOPhio Pharmaceuticals Corp.

$0.87-3.67%10

JUNSJupiter Neurosciences Inc.

$2.46+1.23%10

ASBPAspire Biopharma Holdings Inc.

$7.27-0.41%20

BDPTBioadaptives Inc.

$0.00-5.88%25

TCRTAlaunos Therapeutics Inc.

$1.80-3.23%10

Spot a number that looks wrong? Check it in ADTX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ADTX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.